Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00729677 · ClinicalTrials.gov registry record
Delayed Nausea and Vomiting in Patients With Colorectal Cancer Receiving Oxaliplatin
A clinical trial, sponsored by Beth Israel Medical Center.
- Completed
- Registry status
- 64
- Enrollment target
NCT00729677 is a clinical trial that has completed, run by Beth Israel Medical Center. The registered enrollment target is 64 participants.
The verdict
NCT00729677 has completed, sponsored by Beth Israel Medical Center.
- COMPLETED
- Registry status
- 64 participants
- Enrollment target
Study Summary
RATIONALE: Learning how often patients experience nausea and vomiting after receiving anti-vomiting medicine and chemotherapy for colorectal cancer may help doctors plan better treatment and improve patients' quality of life. PURPOSE: This clinical trial is studying delayed nausea and vomiting in patients with colorectal cancer receiving standard anti-vomiting medicine during the first course of chemotherapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2005-06 |
| Est. Completion | 2008-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00729677
The ClinicalTrials.gov registry entry for NCT00729677 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Medical Center, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00729677 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00729677 about?
NCT00729677 is a clinical study titled "Delayed Nausea and Vomiting in Patients With Colorectal Cancer Receiving Oxaliplatin". RATIONALE: Learning how often patients experience nausea and vomiting after receiving anti-vomiting medicine and chemotherapy for colorectal cancer may help doctors plan better treatment and improve patients' quality of life. PURPOSE: This clinical trial is studying delayed nausea and vomiting in p...
What is the current status of trial NCT00729677?
This trial is currently completed. The enrollment target is 64 participants. The study started on 2005-06. Estimated completion is 2008-12.
Who is sponsoring clinical trial NCT00729677?
This trial is sponsored by Beth Israel Medical Center, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.